Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

An observational study to assess persistence, adherence, quality of life, and treatment satisfaction in patients beginning therapy with the Avonex® PEN™ (PERSIST)
A Herpes Simplex Virus-Derived Replicative Vector Expressing LIF Limits Experimental Demyelinating Disease and Modulates Autoimmunity.
Long-term adherence of patients with relapsing-remitting multiple sclerosis to subcutaneous self-injections of interferon β-1a using an electronic device: the RIVER study.
The American Academy of Neurology's Top Five Choosing Wisely recommendations.
Effect of High-Dose Intravenous Methyl-prednisolone Treatment on Intraocular Pressure in Multiple Sclerosis Patients with Relapse.
The OSCAR-IB Consensus Criteria for Retinal OCT Quality Assessment.
Effects of natalizumab treatment on the CSF proteome of multiple sclerosis patients.
Double Blind Combination of Rituximab by Intravenous and Intrathecal Injection Versus Placebo in Patients With Low-Inflammatory Secondary Progressive Multiple Sclerosis (RIVITaLISe)
Cortical lesion load associates with progression of disability in multiple sclerosis.
Secret talk between adipose tissue and central nervous system via secreted factors-an emerging frontier in the neurodegenerative research.
Normal outcome of pregnancy with ongoing treatment with natalizumab.
Improvement of internuclear ophthalmoparesis in multiple sclerosis with dalfampridine.
Self-perceived performance and satisfaction with performance of daily activities in persons with multiple sclerosis following interdisciplinary rehabilitation.
A Network Meta-Analysis of Efficacy and Evaluation of Safety of Subcutaneous Pegylated Interferon Beta-1a versus Other Injectable Therapies for the Treatment of Relapsing-Remitting Multiple Sclerosis.
Safety Study of RTL1000 (Recombinant T Cell Receptor Ligand) in Subjects with Multiple Sclerosis
Laquinimod prevents inflammation-induced synaptic alterations occurring in experimental autoimmune encephalomyelitis.
Physical activity and associated levels of disability and quality of life in people with multiple sclerosis: a large international survey.
Neural differentiation of patient specific iPS cells as a novel approach to study the pathophysiology of multiple sclerosis.
Parent-of-origin effect in multiple sclerosis: observations in half-siblings.
High dose thiamine improves fatigue in multiple sclerosis.
The little compound that could: how phenytoin changed drug discovery and development.
Gait variability measures reveal differences between multiple sclerosis patients and healthy controls.
Early signs of memory impairment among multiple sclerosis patients with clinically isolated syndrome.
Bullous pemphigoid in a patient with multiple sclerosis being treated with human immunoglobulin.
Early Growth Response Gene-2 Controls IL-17 Expression and Th17 Differentiation by Negatively Regulating Batf.

Pages